ROI Influencers Power List 2024: National & Global Executives
Robert Davis
CEO
Merck
Among other efforts in 2023 was the $10.8 billion acquisition of Prometheus Biosciences, which has a promising experimental treatment for ulcerative colitis and Crohn’s disease.